Israel-based drugmaker Teva Pharmaceutical (TEVA) is snapping up Allergan Plc’s generic drug business for $40.5 billion, the company announced this morning. Under terms of the agreement, Allergan will receive $33.75 billion in cash and shares of Teva valued today at $6.75 billion, representing an estimated under 10 percent ownership stake in Teva, the company said. […]

(Reuters Health) – Chronic depression may more than double the risk of stroke for older adults, and the danger remains high even when mental health improves, a large U.S. study suggests. While previous research has linked depression to greater odds of having a stroke, the current study offers fresh evidence that mood-improving treatments like counseling […]